Literature DB >> 34177431

Potential Pitfalls in Pre-implantation Genetic Diagnosis in a Patient with Tuberous Sclerosis and Isolated Mosaicism for a TSC2 Variant in Renal Tissue.

Kristin M Ikeda1,2, Andrew A House2,3, Dervla M Connaughton2,3, Stephen E Pautler2,4, Victoria Mok Siu2,5, Michelle-Lee Jones1,2.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that displays a wide spectrum of clinical manifestations, often affecting multiple organs including the kidneys, brain, lungs, and skin. A pathogenic mutation in either the TSC1 or TSC2 gene can be detected in almost 85% of the cases, with mosaicism accounting for about half of the remaining cases. We report a case of TSC diagnosed clinically, requesting genetic counselling regarding reproductive risks. No mutation was identified on initial testing of peripheral blood; however, mosaicism for a likely pathogenic frameshift variant in TSC2 was detected at a level of 15% in renal angiomyolipoma tissue. Despite widespread clinical manifestations of TCS, this variant was not detected in skin fibroblasts or saliva, raising the possibility this is an isolated somatic mutation in renal tissue with the underlying germline mutation not yet identified. This case highlights the difficulties when counselling patients with mosaicism regarding their reproductive risks and prenatal diagnostic options.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Genetic counselling; Mosacism; Tuberous sclerosis

Year:  2021        PMID: 34177431      PMCID: PMC8215990          DOI: 10.1159/000513326

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  12 in total

1.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

2.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

3.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Clinical applications of preimplantation genetic testing.

Authors:  Paul R Brezina; William H Kutteh
Journal:  BMJ       Date:  2015-02-19

5.  High rate of mosaicism in tuberous sclerosis complex.

Authors:  S Verhoef; L Bakker; A M Tempelaars; A L Hesseling-Janssen; T Mazurczak; S Jozwiak; A Fois; G Bartalini; B A Zonnenberg; A J van Essen; D Lindhout; D J Halley; A M van den Ouweland
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

6.  A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Authors:  Magdalena E Tyburczy; Sergiusz Jozwiak; Izabela A Malinowska; Yvonne Chekaluk; Trevor J Pugh; Chin-Lee Wu; Robert L Nussbaum; Sara Seepo; Tomasz Dzik; Katarzyna Kotulska; David J Kwiatkowski
Journal:  Hum Mol Genet       Date:  2014-11-28       Impact factor: 6.150

7.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Authors:  T A Smolarek; L L Wessner; F X McCormack; J C Mylet; A G Menon; E P Henske
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

8.  The impact of mosaicism in preimplantation genetic diagnosis (PGD): approaches to PGD for dominant disorders in couples without family history.

Authors:  Roy Pascal Naja; Seema Dhanjal; Alpesh Doshi; Paul Serhal; Joy Delhanty; Sioban B SenGupta
Journal:  Prenat Diagn       Date:  2016-08-31       Impact factor: 3.050

9.  Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission.

Authors:  Krinio Giannikou; Kathryn D Lasseter; Joannes M Grevelink; Magdalena E Tyburczy; Kira A Dies; Zachary Zhu; Lana Hamieh; Bruce M Wollison; Aaron R Thorner; Stephen J Ruoss; Elizabeth A Thiele; Mustafa Sahin; David J Kwiatkowski
Journal:  Genet Med       Date:  2019-06-04       Impact factor: 8.822

10.  Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing.

Authors:  Magdalena E Tyburczy; Kira A Dies; Jennifer Glass; Susana Camposano; Yvonne Chekaluk; Aaron R Thorner; Ling Lin; Darcy Krueger; David N Franz; Elizabeth A Thiele; Mustafa Sahin; David J Kwiatkowski
Journal:  PLoS Genet       Date:  2015-11-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.